U.S. Markets open in 4 hrs 43 mins

Midatech Pharma plc (MTP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.8600-0.0300 (-1.59%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.8900
Open1.8900
Bid0.0000 x 3200
Ask0.0000 x 1100
Day's Range1.8300 - 1.8901
52 Week Range1.6000 - 4.3300
Volume118,613
Avg. Volume2,212,360
Market Cap23.578M
Beta (5Y Monthly)1.75
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Midatech Pharma PLC Announces Appointment of Chief Scientific Officer

    Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific OfficerABINGDON, OXFORDSHIRE / ACCESSWIRE / July 12, 2021 / Midatech Pharma PLC (AIM:MTPH; Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces the appointment of Dr.

  • ACCESSWIRE

    Midatech Pharma PLC Announces Breakthrough Data Using Q-Sphera Technology

    Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technologySignificant progress across multiple other R&D programmesABINGDON, OXFORDSHIRE/ ACCESSWIRE / June 17, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces breakthrough in vitro data which demonstrate Q-Sphera's potential to formulate proteins into long-acting injectable products, as well as signific

  • ACCESSWIRE

    Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021

    ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will be hosting an investor webinar focused on the Company's various R&D programmes at 2.